Description: Epigenomcs AG acts as a holding company and is dedicated to managing its own assets, acquiring, holding and disposing of investments in companies in Germany and abroad, particularly in the field of minimally invasive blood tests for cancer detection, as well as investing in other assets. Latest News
Science Biology Biochemistry and Molecular Biology Gene Expression Products and Services 网站
2024年12月20日